Skip to content

Vitae Pharmaceuticals, Inc

CIK 0001157602

← back to feed
Revenue (TTM)
$391.97K
−47.7% YoY Q2 Jul 2016
Net Income (TTM)
−$43.24M
+12.4% YoY Q2 Jul 2016
EPS Diluted (TTM)
−$1.85
+43.8% YoY Q2 Jul 2016
Gross Margin
—
Q2 Jul 2016
Operating Margin
-11,136.0%
Q2 Jul 2016
Net Margin
-11,032.6%
Q2 Jul 2016
Free Cash Flow (TTM)
—
Q2 Jul 2016
Cash
$24.15M
Q2 Jul 2016
Total Debt
$4.94M
Q2 Jul 2016
Shares Outstanding
28.84M sh
Q2 Jul 2016

Revenue & Net Income

EPS (Diluted)

Margins

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings